San Francisco Biotechnology Network
@sfbionetwork
Followers
2K
Following
304
Media
534
Statuses
23K
San Francisco Biotechnology News and Events, follow jobs at @sfbnjobs
San Francisco, CA
Joined June 2019
StockWatch: Top 3 Biotech ETFs Finally Bounce Back with the Market https://t.co/kI8M49MkB9
#news #biotech
sfbn.org
Biopharma has finally begun catching up with the overall stock market, if the positive returns shown by the top three exchange traded funds (ETFs) since the spring are any indication. Over the past...
0
0
0
Real-World Data Presented at TCT 2025 Demonstrates the EggNest™ Complete Radiation Protection System Significantly Reduces Radiation Exposure for the Entire Cath Lab Team https://t.co/pua22nuPR4
#news #biotech
sfbn.org
SAN FRANCISCO, Oct. 26, 2025 /PRNewswire/ — At the 2025 Transcatheter Cardiovascular Therapeutics® (TCT) Conference, Dr. Jarrod Frizzell of The Christ Hospital (Cincinnati, OH) presented real-world...
0
0
0
California billionaire tax proposal aims to offset health care cuts https://t.co/tIGYIfwH85
#news #biotech
sfbn.org
A proposal to levy a one-time, 5% tax on the net worth of Californians with more than $1 billion is being positioned as an emergency fix to prevent deep health care cuts, and is denounced [...]
0
0
0
Family of Toddler files lawsuit alleging their son died due to daycare neglect https://t.co/r4j4vXnbIh
#news #biotech
sfbn.org
OAKLAND, Calif., Oct. 24, 2025 /PRNewswire/ — The family of two-and-a-half-year-old Matthew Bonneau Junior know that there are moments in life that change you forever. For them, that moment came when...
0
0
0
In push for new infection-fighting drugs, Genentech’s AI seeks no resistance https://t.co/lt0jKaOOZN
#biotech #news
sfbn.org
Finding new antibiotics faster could change the face of antimicrobial resistance. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks
0
0
0
23andMe Research Institute Names Brad Margus and Stephen Quake, D.Phil., to Board of Directors https://t.co/2aE7Q0hUsC
#news #biotech
sfbn.org
23andMe Research Institute Names Brad Margus and Stephen Quake, D.Phil., to Board of Directors Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech...
0
0
0
Neurotronic Announces First Clinical Outcomes of Multi‑Organ Denervation for Type 2 Diabetes and Hypertension https://t.co/0FdMN8vNXD
#news #biotech
sfbn.org
Groundbreaking results from two NECTAR trials to be presented at TCT 2025 SAN FRANCISCO, Oct. 24, 2025 /PRNewswire/ — Neurotronic, Inc., a developer of multi-organ denervation to treat complex...
0
0
0
Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study https://t.co/9P36T8GhHH
#news #biotech
sfbn.org
HAYWARD, Calif.–(BUSINESS WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or...
0
0
0
HanchorBio Presents Phase 1 HCB101 Clinical Results at FACO 2025 Demonstrating Safety and Early Antitumor Activity https://t.co/vcIiOvgYv2
#news #biotech
sfbn.org
FACO 2025 presentation highlights HCB101’s favorable safety, strong receptor occupancy, and confirmed responses in patients with advanced cancers. TAIPEI, SHANGHAI, and SAN FRANCISCO, Oct. 23, 2025...
0
0
0
California Northstate’s Dr. Richard Isaacs builds culture from the bottom up https://t.co/45CYtkm9i2
#biotech #news
sfbn.org
The former Permanente Medical Group executive shares how servant leadership is guiding his $1 billion hospital vision at California Northstate University. Click here to view original post Click Here...
0
0
0
10x, Roche, Prognosys Sue Illumina over Spatial and Single-Cell Patents https://t.co/RD9lgR8V0J
#biotech #news
sfbn.org
10x Genomics has joined with two licensor partners to administer a double dose of litigation to Illumina, filing a pair of federal lawsuits accusing the sequencing giant of infringing on nine patents...
0
0
0
CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart Failure https://t.co/yaSUxLs5e9
#biotech #news
sfbn.org
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentia...
0
0
0
Iovance Biotherapeutics to Host Third Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, November 6, 2025 https://t.co/H8KIRPr5Un
#biotech #news
sfbn.org
SAN CARLOS, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor...
0
0
0
BBOT Presents Preclinical Data Demonstrating Potential of BBO-11818 as a Potent panKRAS Inhibitor at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics https://t.co/BRGWaiMnE4
#biotech #news
sfbn.org
SOUTH SAN FRANCISCO, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) — BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malign...
0
0
0
Get Joy and Blue Zones Founder Dan Buettner Expand Partnership to Unlock Longevity for Dogs — and Their Humans https://t.co/v7rN9mGsae
#biotech #news
sfbn.org
Fresh off the Telly Award–winning “Aging on Paws” docuseries, the collaboration brings proven longevity principles into everyday pet care. NORWALK, Conn., Oct. 23, 2025 /PRNewswire/ — Get Joy, a...
0
0
0
During National Breast Cancer Awareness Month, Alcohol Justice Calls for Recognition of the Breast Cancer-Alcohol Link https://t.co/3f0ewJbdlc
#news #biotech
sfbn.org
Despite Advocates’ Efforts and Extensive Research, Public Awareness Remains Dangerously Low SAN RAFAEL, Calif., Oct. 23, 2025 /PRNewswire/ — October is Breast Cancer Awareness Month, and this year...
0
0
0
Cordis-X Advances FASTEN Trial for Ladera Large Bore Closure System https://t.co/ivQbebXTCj
#news #biotech
sfbn.org
An investigational, suture-based large bore closure device intended to deliver fast and reliable vascular closure MENLO PARK, Calif., Oct. 23, 2025 /PRNewswire/ — Cordis-X today announced that it has...
0
0
0
Generation Lab Raises $11M Seed Round as SystemAge™ Becomes World’s Fastest-Growing Longevity Diagnostic https://t.co/H42V66DqCv
#news #biotech
sfbn.org
Among the top 1% of startup raises, the round will accelerate adoption of the SystemAge breakthrough aging diagnostic platform across 275+ clinics and tens of thousands of people worldwide SAN...
0
0
0
STAT+: Pharmalittle: We’re reading about a Moderna setback, CVS playing hardball with Gilead, and more https://t.co/di3dLQMqvy
#news #biotech
sfbn.org
Top of the morning to you, and a fine one it is. Blue skies and comfortable breezes are enveloping the Pharmalot campus, where the official mascots are dozing after chasing varmints. As for us, we...
0
0
0
CAGE Bio Announces Start of Phase 2 Clinical Trial of Novel Topical DNA Aptamer Therapy CGB-600 for Vitiligo Treatment https://t.co/9nzgPs7shV
#news #biotech
sfbn.org
SAN CARLOS, Calif. and DALLAS, Oct. 23, 2025 /PRNewswire/ — CAGE Bio Inc., a clinical-stage biotechnology company pioneering novel immunomodulatory therapies for dermatological diseases, today...
0
0
0